Return to Listing

1 result(s) for

PI Name Protocol # Title
Emerson Chen STUDY00020600 A Randomized, Double-blind, Placebo-controlled Phase 3 Trial of Pembrolizumab (MK-3475) Versus Placebo in Participants with Esophageal Carcinoma Receiving Concurrent Definitive Chemoradiotherapy (KEYNOTE 975)
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080